Search bioRxiv⌕ Search

Biology subjects

Yang, Z.

Publications and source records attributed to Yang, Z..

At least 145 records · Page 8Linked to original sources
bioRxiv2025

Characterizing Variants of Uncertain Drug Resistance (VUDRs) Using Quantitative Measurements at Clinical Exposures

Somatic missense mutations in oncogenes drive resistance to anticancer drugs, yet many variants remain clinically uncharacterized. Analogous to Variants of Uncertain Significance (VUS) in genetic disorders, these Variants of Uncertain Drug Resistance (VUDRs) in cancer lack the functional annotation needed to guide clinical management. Here, we applied a standards-driven deep mutational scanning platform that connects quantitative concentration-response measurements to human pharmacokinetics across 4922 missense variants (>96% coverage) at approved (400 mg QD) and investigational (400 mg and 500 mg BID) human doses of imatinib. Resistance phenotypes for 18 standards spanning 2 orders of magnitude of drug sensitivity showed strong quantitative performance and clinical concordance. Analyzing 257 clinical VUDRs, >10% conferred modest levels of resistance that might be overcome by dose escalation with generic imatinib instead of a branded alternative, potentially alleviating financial toxicity. Integration with global germline data also revealed ancestry-specific variants with the potential to create private VUDRs. These preclinical data establish the first generalizable framework for high throughput resistance variant classification directly tied to known human doses.

bioengineering↗
bioRxiv2025

Development of an efficient PEG-Mediated protoplast transformation system for the medicinal fungus Ophiocordyceps xuefengensis

Ophiocordyceps xuefengensis is a newly identified medicinal fungus with significant pharmacological and economic value, but its genetic manipulation has been impeded by the lack of an efficient transformation system. Here, we established the first stable and highly efficient polyethylene glycol (PEG)-mediated protoplast transformation platform for O. xuefengensis using hygromycin B as a selectable marker. Through systematic optimization of critical parameters such as enzyme composition, enzyme concentration, mycelial age, and digestion conditions, we developed an optimized protocol for protoplast preparation. A high protoplast yield of 9.42x107 CFU/mL was achieved using 4-day-old mycelia with 1.5% lywallzyme 1 and 1.5% snailase digested at 34{whitebullet}C with shaking at 130 rpm for 3.5 h. PY medium containing 0.6 M mannitol significantly enhanced protoplast regeneration. Stable plasmid integration and robust hygR gene expression were confirmed through PCR detection and sustained antibiotic resistance over four successive generations. Furthermore, a controllable expression system was established by using the endogenous promoter that drove the stable expression of the glycoside hydrolase gene cbhI. The result of enzymatic assay confirmed the functional production of CBHI enzyme, demonstrating the credibility of this system. This work provides a reliable genetic toolbox for functional genomics studies, targeted gene manipulation, and strain engineering in O. xuefengensis, facilitating fundamental research and sustainable utilization of this valuable medicinal species. IMPORTANCEThe conservation and sustainable utilization of medicinal fungi represents a critical challenge in biotechnology and natural product research. Ophiocordyceps xuefengensis, a newly identified species with significant pharmacological potential, exemplifies this challenge: its wild resources are diminishing while artificial cultivation remains restricted by limited understanding of its fundamental biology. The lack of genetic tools has impeded progress in elucidating its biosynthetic pathways, regulating fruiting body development, and enhancing metabolite production. We established a highly efficient PEG-mediated transformation system that directly addresses this technological gap. In addition, we demonstrated that this transformation system can support heterologous gene expression using endogenous promoters. This platform enables reliable genetic manipulation in O. xuefengensis, permitting functional genomics studies and targeted bioactive compounds synthesis.

microbiology↗
bioRxiv2025

The magnitude and durability of neutralizing antibody responses to human papillomavirus vaccine do not depend on DNA sensing pathways

How human papillomavirus (HPV) vaccines elicit robust and enduring neutralizing antibody (nAb) responses is unknown, yet such information is valuable to vaccinology. In addition to the major capsid protein, L1, the 4-valent HPV vaccine reportedly also contains recombinant L1 DNA. Nucleic acids in vaccines can enhance antibody responses, but whether L1 DNA enhances HPV vaccine antibody responses is understudied. We tested whether 9-valent HPV (9vHPV) vaccine lots contained L1 DNA and if peak or long-term 9vHPV vaccine-elicited nAb responses were dependent on DNA sensors TLR9, AIM2, or cGAS, or STING or MyD88, the adaptors for cGAS and TLR9, respectively. To quantify L1 DNA, we extracted total nucleic acid per 9vHPV dose and applied singleplex quantitative PCR to amplify HPV6/11/16/18/31/33/45/52/58 L1 sequences. Wildtype mice (wt; C57BL/6J) or mice deficient in DNA sensing pathways (TLR9-/-, AIM2-/-, cGAS-/-, STINGgt/gt, MyD88-/-) were administered 9vHPV vaccine or equivalent adjuvant only at 0, 4, and 12 weeks. We measured serum HPV16 and HPV18 nAb titers at 16, 26, 40, and 53-56 weeks and HPV16- and HPV18-specific bone marrow plasma cell responses at 53-56 weeks. We detected 5-44 and 104-351 copies of HPV6 and HPV18 L1 DNA per 9vHPV vaccine dose, but no other types (n=3 lots). We found no consistent difference in geometric mean nAb titers between mice strains that received 9vHPV at any time point tested or in median HPV16- or HPV18-specific plasma cell frequencies. Thus, we conclude the magnitude and durability of nAb responses to 9vHPV vaccination do not depend on DNA sensing pathways.

immunology↗
bioRxiv2025

The Whsc2/NelfA -dependent transcription complex is required for postnatal cardiac development and heart function.

Cardiac malformations and ventricular remodeling due to heart diseases result in compromised cardiac function, eventually leading to heart failure. In this study, we examine the role of cardiac Wolf-Hirschhorn Syndrome candidate 2 (Whsc2), also known as Negative elongation factor A (NELFA), one of the genes encoded in the WHS critical region. The Wolf-Hirschhorn Syndrome is a contiguous genetic disorder due to microdeletions in the critical region, with clinical manifestations of neurological defects frequently associated with congenital malformations, including cardiac defects. NelfA has been implicated in RNA polymerase II (pol II) pausing, suggesting a role in pol II-dependent gene transcription. We previously reported an early onset of heart failure with the acute knockdown of NelfA in hearts undergoing pressure overload-induced cardiac hypertrophy. Here, we characterize a mouse model with cardiomyocyte-specific loss of NelfA function, in which these mice develop spontaneous cardiomyopathy at 2 months of age and exhibit early mortality by 3 months, suggesting a critical role for postnatal NelfA in the heart. Interactome data show that chromatin-bound NelfA interacts with proteins involved in chromatin remodeling (Trim28) and pre-mRNA processing (Adrph1l), along with expected binding partners like RNA pol II, Supt5, and other Nelf proteins. Examination of genomic occupancy of these NelfA-associated proteins in the NelfA knockout (KO) hearts reveals a disassembly of the NelfA nucleated complex at promoters of cardiac-enriched genes, including cytoskeletal and metabolic genes. This deconstruction of the NelfA-dependent complex results in the inhibited expression of these essential genes during postnatal cardiac development, leading to a cardiac contractile and metabolic crisis that precipitates dilated cardiomyopathy.

cell biology↗
bioRxiv2025

The Ligand Preference of LRP1 is Regulated by O-glycans

Low-density lipoprotein receptor (LDLR) and LDLR-related proteins (LRPs) are endocytic receptors serving as essential physiological regulators of multiple processes including cholesterol clearance, protein reabsorption and neuronal protein trafficking. We originally discovered O-glycans in linkers of the ligand-binding domains of LDLR/LRP receptors and showed that these play critical roles for uptake of LDL by LDLR and albumin by LRP2. Remarkably, these linker O-glycans are introduced exclusively by GALNT11, one out of 20 polypeptide GalNAc-transferase isoenzymes. Here, we investigate the role of linker O-glycans on the large ([~]600 kDa) and widely expressed multiligand LRP1 receptor implicated in diseases including neuropathies. In genetically engineered cell models we activated endogenous full-coding LRP1 with and without O-glycans and demonstrate that while the uptake of certain ligands, such as RAP and ApoE, was unaffected by O-glycans, the uptake of the neurotoxic molecules tau and amyloid beta was altered and in opposite directions. This demonstrates that O-glycans in ligand-binding domains can differentially modulate ligand affinity and specificity of LRP1. Our findings highlight an overlooked regulatory mechanism of endocytic receptors and identify the ligand repertoire of LRP1 as being influenced by O-glycans, with potential implications for neurodegenerative disease.

molecular biology↗
bioRxiv2025

Rice Ethylene Receptors Function as Ca2+-Permeable Ion Channels to Orchestrate Calcium-Dependent Antagonism of Ethylene Responses in Roots

The gaseous phytohormone ethylene governs essential plant processes spanning development, productivity, and stress resistance. As an essential nutrient and second messenger, calcium (Ca2+) is widely implicated in diverse plant physiological activities; however, its role in the ethylene signal transduction pathway remains elusive. Here, we identified a calcium-dependent antagonism of ethylene response (CAER) specifically modulates root elongation in the model cereal rice (Oryza sativa). Interestingly, we demonstrate that the ethylene receptors OsERS1 and OsERS2 both function as Ca2+-permeable channels, with OsERS1 further acting as a non-selective cation channel capable of permeating both monovalent and divalent cations. Mutagenesis analysis reveals that OsERS1 channel activity relies on homomeric assembly sites (C4/C6) rather than its ethylene-binding site (C65), indicating a clear decoupling of the molecular modules governing receptor signaling and ion channel function. The loss-of-function mutant Osers1/2 does not exhibit the CAER phenotype of the wild type (WT), confirm that this calcium-dependent regulatory mechanism is dependent on both OsERS1 and OsERS2. These findings uncover an unexpected ion-channel function of ethylene receptors, redefining their molecular identity beyond canonical signaling proteins and establishing the novel "hormone receptor-type ion channel (HRIC)" paradigm--one that fundamentally expands our understanding of how plant hormones transduce signals at the membrane.

developmental biology↗
bioRxiv2025

A spatially-resolved human brain proteome atlas for understanding function and disease

While the brain performs specialized functions across distinct regions, the spatial organization of the human brain proteome remains largely uncharted. Here we present a comprehensive spatially-resolved proteome atlas of the human brain, analyzing over two thousand MRI- guided locations across four individuals. Proteome analysis integrated with transcriptomics reveals extensive post-transcriptional regulation, with cortical regions showing markedly higher protein diversity than transcript. Unsupervised molecular clustering defines distinct brain territories that transcend anatomical boundaries, instead reflecting metabolic demands and functional specialization patterns. Application to epilepsy brain tissue uncovered disrupted astrocyte metabolism, protein homeostasis and therapeutic targets including the seizure-associated purinergic receptor P2RX7. This resource bridges molecular and systems neuroscience to accelerate neurological drug discovery.

neuroscience↗
bioRxiv2025

Hypercholesterolemia Risk Prediction from Serum Metabolomics Using a Metabolic Pathway-Integrated Graph Neural Network

In this paper, we presents a new machine learning framework called the Metabolic Pathway Graph Neural Network (MP-GNN), aimed at predicting hypercholesterolemia risk based on serum metabolomics data. Many existing analytical frameworks for analyzing metabolites in clinical applications overlook the complex biochemical relationships that exist among metabolites. MP-GNN explicitly takes advantage of existing knowledge about metabolic pathways by incorporating that information into graph templates where metabolites are represented as nodes and metabolic pathway interactions between metabolites are represented as edges. A comparative analysis of MP-GNN was conducted with a large-scale study of population metabolomics against several conventional machine learning and several state-of-the-art machine learning methods. The results of the simulation indicated that MP-GNN was able to provide for highly accurate prediction of risk, and importantly, provide interpretability that was biologically meaningful based on findings in the literature. Importantly, the analysis revealed several key metabolites, and also several biological metabolic pathways that were found to be significant related to prediction, which were consistent with findings in biological studies. The findings support the potential of MP-GNN to leverage prior biological knowledge to enhance predictive performance and expand our ability to gain insight into complex diseases.

bioengineering↗
bioRxiv2025

Neural Underpinnings of Olfactory Dysfunction across Parkinson's and Alzheimer's Spectra

Olfactory dysfunction is a frequent yet understudied feature of neurodegenerative spectrum disorders, including Alzheimers disease (AD) and Parkinsons disease (PD). To disentangle the neural substrates of hyposmia across disease spectra, we examined 222 participants from the Parkinsons and Alzheimers disease Dimensional Neuroimaging Initiative cohort. Participants were classified according to the presence of cognitive disturbance, movement disorder, or both. Olfactory testing disclosed that cognitive disturbance and movement disorder were independently associated with hyposmia, and having both cognitive disturbance and movement disorder was associated with severe hyposmia. Whole-brain voxel-based morphometry revealed that hyposmia was associated with atrophy in the medial temporal lobe (MTL) in individuals with cognitive disturbance, whereas an artificial intelligence-based segmentation model identified olfactory bulb atrophy in those with movement disorder. Regression analysis and structural equation modeling further confirmed that the MTL and olfactory bulb volume contributed to olfactory performance through distinct processes. Individuals with cognitive disturbance and movement disorder had atrophy in both the MTL and olfactory bulb ("double hit"). We identified dual processes underlying hyposmia in the AD and PD spectra: a process linking MTL degeneration to cognitive disturbance and a process linking olfactory bulb degeneration to movement disorder. Our transdiagnostic approach enhances strategy in identifying specific neural correlates underlying hyposmia, lending support to the development of biomarkers for early intervention in AD and PD.

neuroscience↗
bioRxiv2025

Nanobody-Driven Stabilization Synergistically Rescues F508del-CFTR and Reveals an Alternative Active State of the Channel

Defects in protein trafficking underlie many genetic diseases, including cystic fibrosis (CF), where the predominant F508del mutation destabilizes the cystic fibrosis transmembrane conductance regulator (CFTR) channel, leading to its degradation. To provide a protein-specific chaperone, we used lipid nanoparticles to deliver mRNA encoding T2a, a nanobody that thermally stabilizes CFTR via high-affinity binding to nucleotide-binding domain 1 (NBD1). When combined with clinically-approved correctors, T2a considerably improved F508del-CFTR maturation, plasma membrane expression, and channel activity. Single-channel recordings revealed that nanobody binding sustained channel activity by promoting both full open and sub-conductance gating states and protecting F508del-CFTR against thermal deactivation. Because T2a binding to NBD1 prevents the ATP-dependent NBD1-NBD2 association that drives canonical channel opening, the observation of channel activity in the presence of the nanobody suggested adoption of a novel open-channel CFTR structure. This inference was confirmed by cryo-EM analyses of CFTR in the presence of T2a, which revealed a novel open-channel conformation in which NBD1 binds to an alternative site on CFTR incompatible with NBD dimerization. Our findings establish a new paradigm to correct protein trafficking by stabilizing misfolded domains with targeted nanobodies and demonstrate a broadly applicable framework to treat CF and related protein misfolding diseases.

biochemistry↗
bioRxiv2025

A Multiplexed Fluorescent Microsphere Immunoassay of IgG Antibodies to the Individual Glycose Antigens of the Neisseria Lipooligosaccharide α Chain in Clients of an STI Clinic

BackgroundTo evaluate the immunogenicity of lipooligosaccharide (LOS) based gonococcal vaccines, we developed a multiplexed fluorescent microsphere immunoassay that distinguishes and quantifies antibodies that bind the various LOS antigens. MethodsWe coupled LOS from gonococcal strains 1291wt (nLc4 chain), 1291a (Lc3 chain) and 1291c (Lc2 chain), to different fluorescent microsphere regions (BioRad) after disaggregation in 1% deoxycholate. The microspheres were incubated with sera from 37 participants in a study of gonococcal risk factors. Laser excited fluorescence from each region was converted to ng/mL of IgG with use of affinity purified human IgG specific for each LOS. IgG specific to the nLc4 terminal galactose was quantified by subtraction of Lc3 IgG from 1291wt IgG; that specific to the Lc3 terminal glucosamine by subtraction of Lc2 IgG from Lc3 IgG. ResultsConcentrations of nLc4, Lc3 and Lc2 IgG summed to the concentration of 1291wt IgG. Visual inspection of the data revealed a non-normally distributed, bimodal distribution of nLc4 IgG concentrations; 31/37 had a mean serum nLc4 IgG concentration of 6.22 ng/mL, and the other six had a mean nLc4 IgG concentration of 11.2 ng/ml. Upon statistical comparison of these groups, conducted prior to knowledge of infection status, those participants whose nLc4 IgG concentration centered around a higher mean, were more likely to be asymptomatic (p = 0.03) and were less likely to be infected (p = 0.05) than those with lower IgG concentrations. ConclusionsThis accurate LOS immunoassay can be expanded to include any number of LOS specificities. Short SummaryWe developed a multiplexed fluorescent microsphere immunoassay of IgG antibodies to glycose antigens of the Neisseria Lipooligosaccharide in clients of an STI clinic who were sexually exposed to gonorrhea.

immunology↗
bioRxiv2025

A New Aneurysm Rupture-Prone Marfan Mouse Model with FBN1Q2467X Nonsense Mutation Reveals Adventitial Inflammation

Marfan syndrome (MFS) is a genetic disorder caused by mutations in fibrillin-1(FBN1), which encodes FBN1, a key structural component of the extracellular matrix. Mutations in FBN1 influence the severity of aortic disease and therapeutic responses, with aortic aneurysm being the leading cause of mortality in patients with MFS. To investigate the mechanisms driving aneurysm progression, we generated a mouse model (Fbn1Q2469X/+) carrying the FBN1Q2467X nonsense mutation identified in MFS patients. This mutation results in FBN1 deficiency. Although Fbn1Q2469X/+ mice appear normal, showing only mild, nonprogressive dilation of the aortic root and ascending aorta with minor reductions in blood pressure, homozygous Fbn1Q2469X/Q2469X mice develop spontaneous thoracic aortic aneurysms (TAA) that progress to rupture between 10 and 25 days of age, with 100% penetrance. Histopathology shows progressive vessel wall degeneration characterized by disorganized vascular smooth muscle cells, collagen loss, and elastic fiber fragmentation from early to late stages. RNA-seq analysis identifies inflammation as the dominant process in late-stage aneurysms. Immunofluorescence assay reveals inflammatory cells prominently localized to the adventitia near rupture sites, linking adventitial inflammation to aneurysm progression. This genetically modified Fbn1Q2469X/Q2469X mouse model consistently develops progressive aortic aneurysms and provides a reliable, cost-effective platform to investigate the molecular mechanisms of aneurysm progression and to evaluate therapeutic strategies in aneurysm diseases, including Marfan syndrome and related disorders.

genetics↗
bioRxiv2025

Novel Calcin peptides from Scorpion Venom Exhibit Humidity-Dependent Expression and Ryanodine Receptor Activation

Scorpions are venomous animals of considerable pharmacological potential, traditionally used in East Asia to treat cardiovascular and autoimmune diseases. However, geographical variations in the expression of their venom components remain poorly understood. We performed transcriptome profiling on scorpion samples collected from eight distinct climatic and environmental regions in East Asia, we successfully identified two distinct scorpion species: Uroctonus mordax and Mesobuthus martensii. Furthermore, we identified two novel calcins from the venoms of these species, with their expression levels showing a significant correlation to environmental humidity. Functional assays revealed that these calcins differentially potentiate [3H]ryanodine binding to RyR isoforms and induce a persistent subconductance state, suggesting distinct mechanisms of action. Our findings suggest biogeographical variation in venom composition between species and suggest that environmental humidity as a key factor influencing calcin expression. These results expand the structural diversity of the calcin family and provide a mechanistic basis for the medicinal application and ecological adaptation of scorpion venom.

molecular biology↗
bioRxiv2025

Phosphorylation enables progressive microtubule-associated protein proteolysis and functionalisation during neural development

Neurological diseases are frequently characterised by dysregulation of the microtubule cytoskeleton, which is critical for neuronal integrity and functioning. However, the precise mechanisms by which microtubule dynamics are regulated during the development of the nervous system remain poorly understood. Here, we use global phosphoproteomic screening to identify cytoskeletal substrates of Ser-Arg Protein Kinase (SRPK), which is implicated in several neurodevelopmental and neurodegenerative conditions. We show that SRPK directly phosphorylates Microtubule Associated Protein (MAP)1S at multiple sites in a C-terminal region involved in proteolytic maturation and microtubule binding. SRPK-dependent MAP1S phosphorylation modulates the affinity of the MAP1S microtubule binding domain for microtubules and MAP1S proteolytic processing by the Calpain (CAPN)10 protease. Finally, we show that MAP1S proteolytic processing occurs progressively during neurodevelopment via a specific CAPN10 expression switch, corresponding with MAP1S acquisition of microtubule binding activity. Our results demonstrate a role for SRPK in coordinating processing and functionalisation of a key microtubule regulatory protein during neurodevelopment and provide insight into mechanisms by which the microtubule cytoskeleton may be dysregulated in neurological diseases.

biochemistry↗
bioRxiv2025

Identification of a broad and potent V3 glycan site bNAb targeting anN332gp120 glycan-independent epitope

Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia in vivo and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral activity against multiclade pseudovirus panels1-3 (GeoMean IC50 = 0.012 {micro}g/mL, breadth = 69%, 217 virus strains) by targeting a N332gp120 glycan-independent V3 epitope, a site of Env vulnerability to which only weakly neutralizing antibodies had previously been identified. Functional analyses demonstrated distinct binding and neutralization profiles compared to classical V3 glycan site bNAbs. A 007 Fab-Env cryo-EM structure revealed contacts with the V3 324GD/NIR327 motif and interactions with N156gp120 and N301gp120 glycans. In contrast to classical V3 bNAbs, 007 binding to Env does not depend on the N332gp120 glycan, rendering it resistant to common escape mutations. Structures of 007 IgG-Env trimer complexes showed two Env trimers crosslinked by three bivalent IgGs, and bivalent 007 IgG was up to [~]300-fold more potent than monovalent 007 IgG heterodimer, suggesting a role for avidity in potent neutralization. Finally, in HIV-1ADA-infected humanized mice, 007 caused transient decline of viremia and overcame classical V3 escape mutations, highlighting 007s potential for HIV-1 prevention, therapy, functional cure, and vaccine design.

immunology↗
bioRxiv2025

Bayesian inference of introgression between sister lineages using genomic data

Inference of interspecific gene flow using genomic data is important to reliable reconstruction of species phylogenies and to our understanding of the speciation process. Gene flow is harder to detect if it involves sister lineages than nonsisters; for example, most heuristic methods based on data summaries are unable to infer gene flow between sisters. Likelihood-based methods can identify introgression between sisters but the test exhibits several nonstandard features, including boundary problems, indeterminate parameters, and multiple routes from the alternative to the null hypotheses. In the Bayesian test, those irregularities pose challenges to the use of the Savage-Dickey (S-D) density ratio to calculate the Bayes factor. Here we develop a theory for applying the S-D approach under nonstandard conditions. We show that the Bayesian test of introgression between sister lineages has low false-positive rates and high power. We discuss issues surrounding the estimation of the rate of gene flow between sister lineages, especially at very low or very high rates, and suggest that evidence for gene flow between sisters be assessed via a Bayesian test. We find that the species split time has a major impact on the information content in the data, with more information at deeper divergence. We use a genomic dataset from Sceloporus lizards to illustrate the test of gene flow between sister lineages.

evolutionary biology↗
bioRxiv2025

Macrophages drive a fibrogenic gene program of periductal fibroblasts in pediatric primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) is an autoimmune, cholestatic liver disease characterized by inflammation and fibrosis surrounding bile ducts. The cellular crosstalk driving periductal fibrosis remains poorly defined. This study applied a multi-omics approach integrating MERSCOPE spatial transcriptomics, bulk RNA-seq, and SomaScan proteomics to characterize fibrotic periductal regions and their cell-cell communications. Macrophages (MP) expressing moderate-to-high CD163 were found co-localized with cholangiocytes, T cells, and collagen-producing hepatic stellate cells (HSC). Cell niche analysis identified periductal regions with elevated fibrotic signals, in which cell-cell communication analysis revealed MP-HSC interactions involving 17 fibrotic driver genes in MP (e.g., IFNGR1, CSF1R, CD163) and six fibrotic effector genes in HSC (e.g., COL1A2, VCAN, MMP2). In validation analyses, bulk RNA-seq data showed higher driver and effector gene scores in PSC with established fibrosis compared to early-stage PSC and autoimmune hepatitis (AIH). Plasma proteins encoded by MP driver genes were elevated in autoimmune liver disease (AILD) and in patients with elevated ([≥]3.29 kPa) liver stiffness on MR elastography. These findings suggest that macrophages engage in localized crosstalk with HSC, activating fibrotic gene programs and contributing to periductal fibrosis in PSC, thereby identifying potential molecular targets for therapeutic intervention.

immunology↗